UiPath Inc. (NYSE:PATH) is one of the cheap AI stocks to buy according to analysts. On April 27, UiPath and Deloitte expanded their collaboration to accelerate software development, testing, and deployment for global organizations. The joint solution integrates UiPath Test Cloud capabilities into Deloitte’s Ascend engineering and service delivery platform.
The partnership focuses heavily on agentic AI, enabling autonomous quality through AI agents that work alongside human testers. Powered by agentic AI, the solution proactively detects system changes, generates tests, and executes them autonomously. Testers can use these AI agents to analyze thousands of test results, identify root causes, and uncover failure patterns.
By embedding UiPath Inc. (NYSE:PATH) Autopilot for Testers and Agent Builder into Ascend, teams can utilize prebuilt testing bots and domain-specific AI agents. This AI-driven integration is designed to automate manual tasks like test design and reduce maintenance through self-healing execution, resulting in broader test coverage, faster release cycles, and higher automation ROI.
UiPath Inc. (NYSE:PATH) is an AI-powered software infrastructure company that integrates generative and agentic AI with robotic process automation/RPA through its primary offering, the UiPath platform.
While we acknowledge the potential of PATH as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you’re looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock.
READ NEXT: 33 Stocks That Should Double in 3 Years and Cathie Wood 2026 Portfolio: 10 Best Stocks to Buy.
Disclosure: None. Follow Insider Monkey on Google News.
